Patient Master

SPRAVATO® nasal spray device

SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:

  • Adults with treatment-resistant depression
    XIn the SPRAVATO® clinical trials, treatment-resistant depression was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current episode.
  • Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions
    XSymptoms associated with major depressive disorder may include:
    • Depressed mood or feelings of sadness
    • Disrupted sleep
    • Lack of interest or inability to feel pleasure (anhedonia)
    • Feelings of guilt or hopelessness
    • Lack of energy
    • Difficulty concentrating
    • Changes in appetite or weight
    • Slowed thoughts or movements (psychomotor retardation)
    • Restlessness and/or purposeless movements (psychomotor agitation)
    • Suicidal thoughts or actions

Help is available 24/7. If you’re struggling with suicidal thoughts, call the National Suicide Prevention Lifeline: 1-800-273-8255.

Help is available 24/7. If you’re struggling with suicidal thoughts, call the National Suicide Prevention Lifeline: 1-800-273-8255.

The National Suicide Prevention Lifeline is a federally funded network of crisis centers committed to suicide prevention.